DrugDashboards

Ceftriaxone

Ceftriaxone · CEFTRIAXONE SODIUM 10 g/1 · Injection, Powder, For Solution · Intravenous · WG Critical Care, LLC

NDC 44567-0703-01 · 1 VIAL, PHARMACY BULK PACKAGE in 1 CARTON / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, PHARMACY BULK PACKAGE · ANDA · View full market →

The short version

6 companies supply this market — a reasonable cushion if one runs into trouble. The price is down 8% over the past year, to $25.21 per unit. Historically, drugs in this position went on to a new shortage within 90 days about 0.4% of the time — roughly 3× the typical drug (0.1%).

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

One drug, every price

The same NDC has different prices depending on who is paying. Units differ between rungs — compare within a rung over time, not rung against rung, unless the units match.

ⓘ How this was built
Data sources
  • CMS NADAC (pharmacy acquisition, weekly)
  • CMS Part B ASP quarterly payment limits
  • CMS Maximum Fair Prices (IRA negotiated, NDC-level)
  • Medicare Part D Spending by Drug (data.cms.gov, name-matched)
  • VA FSS / Big4 federal contract prices (va.gov, twice monthly)
  • ACA Federal Upper Limits + weighted AMP (data.medicaid.gov, monthly)
  • California SB-17 WAC filings (list price, per package)
Method

Each rung is the newest figure for this NDC from one federal price system, shown with its own unit. Part D is matched by drug name because CMS publishes no NDCs there; it is gross spending, before confidential rebates.

Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.

  • Medicare Part B pays (ASP+6%)$0.4040per billing unit (250 MG)HCPCS J0696 · Jul 1, 2026
  • Part D plans paid (avg)$12.85per dosage unitgross, before rebates — matched by drug name · 2024
  • Federal contracts pay (FSS)$10.15per unitWG Critical Care, LLC · Jul 4, 2024

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

$0$10.00$20.00$30.00Jan 2014Nov 2014$25.21
2 price points · per · last surveyed Invalid DateSource: CMS NADAC

Estimated fill cost

WAC per package, as filed
$26.60
Reported to Texas DSHS · 2026 annual filing · WG Critical Care

Manufacturer list price as filed — not what pharmacies actually pay after discounts.

Medicare Part B (ASP)

Payment limit per 250 MG
$0.404
HCPCS J0696 · Jul 1, 2026 quarter · typically ASP + 6%

Medicaid spend (2025)

$46,058
2,995 prescriptions paid by Medicaid nationally · all Medicaid spend →

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

90-day shortage risk (model v2)

0.4%chance of a new FDA shortage posting for ceftriaxone (injectable) in the next 90 days

sterile injectable · sole-source market

For scale: the typical drug’s chance is about 0.1% — this one is 3× that.

Backtested statistical model over the whole market, not this package alone. Model details →

Is this a "specialty" drug?

There's no legal definition — it meets 1 of 6 public criteria. Why that matters →

  • Part D specialty tier
  • Costs ≥ $950/fill · avg $114.40 per prescription
  • Biologic (BLA)
  • Injectable / infused
  • Orphan-drug exclusivity
  • REMS program

Regulatory

Application
ANDA065328
TE code
AP
Approval date
Jul 24, 2008
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Ceftriaxone (Injection, Powder, For Solution)

LabelerStrengthFirst seenLast seen
WG Critical Care, LLCCEFTRIAXONE SODIUM 2 g/1Jul 15, 2026Sep 3, 2026
Civica, Inc.CEFTRIAXONE SODIUM 2 g/1Jul 15, 2026Sep 2, 2026
Civica, Inc.CEFTRIAXONE SODIUM 1 g/1Jul 15, 2026Sep 2, 2026
Fresenius Kabi USA, LLCCEFTRIAXONE SODIUM 1 g/1Jul 15, 2026Sep 2, 2026
Hikma Pharmaceuticals USA Inc.CEFTRIAXONE SODIUM 250 mg/1Jul 15, 2026Sep 2, 2026
Hikma Pharmaceuticals USA Inc.CEFTRIAXONE SODIUM 500 mg/1Jul 15, 2026Sep 2, 2026
Hikma Pharmaceuticals USA Inc.CEFTRIAXONE SODIUM 1 g/1Jul 15, 2026Sep 2, 2026
Hikma Pharmaceuticals USA Inc.CEFTRIAXONE SODIUM 10 g/1Jul 15, 2026Sep 2, 2026
Hikma Pharmaceuticals USA Inc.CEFTRIAXONE SODIUM 2 g/1Jul 15, 2026Sep 2, 2026
Proficient Rx LPCEFTRIAXONE SODIUM 2 g/1Jul 15, 2026Sep 2, 2026
Sagent PharmaceuticalsCEFTRIAXONE SODIUM 2 g/1Jul 15, 2026Sep 2, 2026
Sagent PharmaceuticalsCEFTRIAXONE SODIUM 1 g/1Jul 15, 2026Sep 2, 2026
WG Critical Care, LLCCEFTRIAXONE SODIUM 500 mg/1Jul 15, 2026Sep 2, 2026
WG Critical Care, LLCCEFTRIAXONE SODIUM 10 g/1Jul 15, 2026Sep 2, 2026
WG Critical Care, LLCCEFTRIAXONE SODIUM 1 g/1Jul 15, 2026Aug 31, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Ceftriaxone — NDC 44567-0703-01," retrieved September 3, 2026, https://drugdashboards.com/drug/44567070301.

Free to cite with attribution — see how the data is put together.